Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
about
Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever VirusCorrelative Gene Expression to Protective Seroconversion in Rift Valley Fever VaccinatesDeletion mutants of Schmallenberg virus are avirulent and protect from virus challengeRift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.Current Status of Rift Valley Fever Vaccine Development.Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination.Evaluation of Fluorescence Microsphere Immunoassay for the Detection of Antibodies to Rift Valley Fever Nucleocapsid Protein and Glycoproteins.
P2860
Q26315437-C0C4C312-3061-4018-AD55-5B062420E017Q27330115-A309440E-017C-4963-9C62-7749E26BEA6BQ34991418-3495F5D3-816A-44F9-AC3C-567E645F9981Q39251803-74276379-7821-44A0-932F-EA8A1B8FC393Q41929716-05F8D4F5-9088-42A0-8650-5C6CB15DBF79Q50329180-18BCA080-4023-48C9-828F-E3776C65870EQ54251506-75B7759D-B201-4110-B105-4F116B3CCD87
P2860
Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Efficacy of a recombinant Rift ...... a vaccine candidate in sheep.
@en
Efficacy of a recombinant Rift ...... a vaccine candidate in sheep.
@nl
type
label
Efficacy of a recombinant Rift ...... a vaccine candidate in sheep.
@en
Efficacy of a recombinant Rift ...... a vaccine candidate in sheep.
@nl
prefLabel
Efficacy of a recombinant Rift ...... a vaccine candidate in sheep.
@en
Efficacy of a recombinant Rift ...... a vaccine candidate in sheep.
@nl
P2093
P1433
P1476
Efficacy of a recombinant Rift ...... a vaccine candidate in sheep.
@en
P2093
Charles K Nfon
George E Bettinger
Hana M Weingartl
John C Morrill
Peter Marszal
Shunzhen Zhang
William C Wilson
P304
P356
10.1016/J.VACCINE.2013.12.064
P407
P577
2014-01-24T00:00:00Z